PXDN and metastatic malignant neoplasm in the lymph nodes: In breast cancer, PXDN overexpression is associated with advanced tumor grade, lymph node metastasis, and distant dissemination; patients with high PXDN expression exhibit reduced disease-free and overall survival [21].